¹⁵O-water PET Imaging System

About MedTrace

MedTrace is a Copenhagen-based biotech innovator, founded in 2018, focused on transforming perfusion imaging for cardiovascular disease. The company's core technology is an automated, on-site system for producing and infusing the PET tracer Oxygen-15 water, combined with its aQuant analytical software, to provide quantitative myocardial blood flow measurements. While the technology is recognized as a gold standard in research, MedTrace is navigating the regulatory path, with a Phase 3 trial ongoing in the US and a CE mark for its software in Europe, positioning it to address a significant unmet need in non-invasive cardiac diagnostics. The company is privately held and appears to be in a pre-revenue, late-clinical development stage.

Therapeutic Areas